Cas no 3590-36-1 (5-Methylcytidine-5'-monophosphate)
5-Methylcytidine-5'-monophosphate Chemical and Physical Properties
Names and Identifiers
-
- Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) (8CI)
- 5-Methylcytidine 5'-(dihydrogen phosphate)
- 5-Methylcytidine 5'-monophosphate
- 5-Methylcytidylic acid
- 5-methyl-CMP
- 5-Methylcytidine-5'-Monophosphate
- [(2R,3S,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
- 5-Methyl-5'-cytidylic acid
- 5-methylcytidine monophosphate
- 5-methylcytidine 5'-phosphate
- 5'-Cytidylic acid, 5-methyl-
- ((2R,3S,4R,5R)-5-(4-Amino-5-methyl-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyldihydrogenphosphate
- CHEBI:74725
- AC-32430
- PD060192
- NM29555
- ((2R,3S,4R,5R)-5-(4-Amino-5-methyl-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
- 117309-80-5
- Q27144859
- [(2R,3S,4R,5R)-5-(4-amino-5-methyl-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate
- NS00070869
- 5MC
- 3590-36-1
- {[(2R,3S,4R,5R)-5-(4-amino-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid
- 4-Imino-5-methyl-1-(5-O-phosphonopentofuranosyl)-1,4-dihydropyrimidin-2-ol
- SCHEMBL3504106
- CHEMBL72388
- 5-Methyl-CMP;m5CMP
- DB01995
- DTXSID20922391
- 5-Methylcytidine-5'-monophosphate
-
- Inchi: 1S/C10H16N3O8P/c1-4-2-13(10(16)12-8(4)11)9-7(15)6(14)5(21-9)3-20-22(17,18)19/h2,5-7,9,14-15H,3H2,1H3,(H2,11,12,16)(H2,17,18,19)/t5-,6-,7-,9-/m1/s1
- InChI Key: NJQONZSFUKNYOY-JXOAFFINSA-N
- SMILES: P(=O)(O)(O)OC[C@@H]1[C@H]([C@H]([C@H](N2C(N=C(C(C)=C2)N)=O)O1)O)O
Computed Properties
- Exact Mass: 337.06750147g/mol
- Monoisotopic Mass: 337.06750147g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 8
- Heavy Atom Count: 22
- Rotatable Bond Count: 4
- Complexity: 573
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -3.7
- Topological Polar Surface Area: 175
Experimental Properties
- Density: 2.04±0.1 g/cm3 (20 oC 760 Torr),
- Solubility: Soluble (610 g/l) (25 o C),
5-Methylcytidine-5'-monophosphate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M211315-1mg |
5-Methylcytidine-5'-monophosphate |
3590-36-1 | 1mg |
$ 250.00 | 2022-06-04 | ||
| TRC | M211315-2.5mg |
5-Methylcytidine-5'-monophosphate |
3590-36-1 | 2.5mg |
$ 390.00 | 2022-06-04 | ||
| TRC | M211315-5mg |
5-Methylcytidine-5'-monophosphate |
3590-36-1 | 5mg |
$ 825.00 | 2022-06-04 | ||
| A2B Chem LLC | AF84899-1mg |
Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) (8CI) |
3590-36-1 | 1mg |
$257.00 | 2024-04-20 | ||
| A2B Chem LLC | AF84899-2mg |
Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) (8CI) |
3590-36-1 | 2mg |
$350.00 | 2024-04-20 | ||
| A2B Chem LLC | AF84899-5mg |
Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) (8CI) |
3590-36-1 | 5mg |
$500.00 | 2024-04-20 | ||
| A2B Chem LLC | AF84899-10mg |
Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) (8CI) |
3590-36-1 | 10mg |
$725.00 | 2024-04-20 | ||
| A2B Chem LLC | AF84899-25mg |
Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) (8CI) |
3590-36-1 | 25mg |
$1350.00 | 2024-04-20 | ||
| eNovation Chemicals LLC | Y4055723-100mg |
Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) |
3590-36-1 | 98% | 100mg |
$255 | 2025-08-06 | |
| eNovation Chemicals LLC | Y4055723-250mg |
Cytidine, 5-methyl-, 5'-(dihydrogen phosphate) |
3590-36-1 | 98% | 250mg |
$335 | 2025-08-06 |
5-Methylcytidine-5'-monophosphate Suppliers
5-Methylcytidine-5'-monophosphate Related Literature
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
-
Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Jason Wan Lab Chip, 2020,20, 4528-4538
Related Categories
- Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Pyrimidine nucleotides Pyrimidine ribonucleoside monophosphates
- Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Pyrimidine nucleotides Pyrimidine ribonucleotides Pyrimidine ribonucleoside monophosphates
Additional information on 5-Methylcytidine-5'-monophosphate
Recent Advances in the Study of 5-Methylcytidine-5'-monophosphate (CAS: 3590-36-1) and Its Applications in Chemical Biology and Medicine
5-Methylcytidine-5'-monophosphate (5-MeCMP, CAS: 3590-36-1) is a modified nucleotide that plays a critical role in epigenetic regulation and RNA biology. Recent studies have highlighted its significance in various biological processes, including gene expression modulation, RNA stability, and cellular differentiation. This research briefing synthesizes the latest findings on 5-MeCMP, focusing on its chemical properties, biological functions, and potential therapeutic applications.
One of the most notable advancements in the study of 5-MeCMP is its role in RNA methylation. Researchers have discovered that 5-MeCMP serves as a key intermediate in the biosynthesis of 5-methylcytosine (5-mC) in RNA, which is catalyzed by RNA methyltransferases. This modification has been linked to the regulation of mRNA translation and stability, offering new insights into post-transcriptional gene regulation. A 2023 study published in Nature Chemical Biology demonstrated that 5-MeCMP incorporation into RNA can influence the binding affinity of RNA-binding proteins, thereby modulating downstream signaling pathways.
In addition to its biological functions, 5-MeCMP has garnered attention for its potential therapeutic applications. Recent preclinical studies have explored its use in the development of novel antiviral and anticancer agents. For instance, a 2022 study in Journal of Medicinal Chemistry reported that 5-MeCMP derivatives exhibit inhibitory activity against certain RNA viruses by interfering with viral replication machinery. Furthermore, its role in epigenetic modulation has spurred interest in its application for treating diseases characterized by aberrant DNA methylation, such as cancer and neurodegenerative disorders.
The synthesis and characterization of 5-MeCMP have also seen significant progress. Advanced analytical techniques, such as high-performance liquid chromatography (HPLC) coupled with mass spectrometry (MS), have enabled precise quantification and structural analysis of 5-MeCMP in complex biological samples. A 2023 paper in Analytical Chemistry detailed a novel method for detecting 5-MeCMP in cellular RNA, providing a valuable tool for researchers studying its biological roles.
Despite these advancements, challenges remain in the clinical translation of 5-MeCMP-based therapies. Issues such as delivery efficiency, metabolic stability, and off-target effects need to be addressed. Ongoing research is focused on optimizing the pharmacokinetic properties of 5-MeCMP derivatives and developing targeted delivery systems to enhance their therapeutic efficacy.
In conclusion, 5-Methylcytidine-5'-monophosphate (CAS: 3590-36-1) represents a promising area of research in chemical biology and medicine. Its dual role as an epigenetic modulator and a potential therapeutic agent underscores its versatility and importance. Future studies will likely uncover new mechanisms of action and expand its applications in disease treatment and diagnostics.
3590-36-1 (5-Methylcytidine-5'-monophosphate) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)